CTRI/2024/05/067087尚未招募Unknown
DETERMINATION OF THE RISK PREDICTION OF CARDIOVASCULAR DISEASE AS PER PRAKRITI AMONG PATIENTS OF DIABETES MELLITUS type-2
Chaudhary Brahm Prakash ayurved Charak Sansthan0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1 Individuals of both sexes with or without associated risk factors.
- •2 Individuals willing to participate in this study and has given his consent.
- •3 Individuals having no history of any apparent disease in last one month.
排除标准
- •No past history of cardiovascular events namely Coronary heart disease Stroke etc at the time of enrolment or no evidence of past cardiovascular event and other Individuals with known risk factors on evaluation shown evidence of cardiovascular complications
研究者
相似试验
进行中（未招募）
1 期
Cardiovascular (CV) risk prediction and CV biomarkers in renal transplant recipients treated with belatacept compared to calcineurin inhibitors (CNI)Open randomized 12 month studyEUCTR2013-001178-20-SEppsala University Hospital, MHT, Department of Nephrology105
进行中（未招募）
1 期
Cardiovascular (CV) risk prediction and CV biomarkers in renal transplant recipients treated with belatacept compared to calcineurin inhibitors (CNI)Open randomized 12 month studyProphylaxis of graft rejection in adults who have received a renal transplantMedDRA version: 20.0Level: LLTClassification code 10050436Term: Prophylaxis against renal transplant rejectionSystem Organ Class: 100000022818EUCTR2013-001178-20-DKppsala University Hospital, MHT, Department of Nephrology110
进行中（未招募）
1 期
Does conversion to Nulojix reduce the risk of cardiovascular disease in kidney transplant recipients?Prophylaxis of graft rejection in adults who have received a renal transplantMedDRA version: 17.1Level: LLTClassification code 10050436Term: Prophylaxis against renal transplant rejectionSystem Organ Class: 100000004865EUCTR2013-001178-20-NLppsale University Hospital, MHT, Department of Nephrology105
已完成
4 期
Cardiovascular (CV) risk prediction and CV biomarkers in renal transplant recipients treated with belatacept compared to calcineurin inhibitors (CNI).;Open randomized 12 month study.cardiovascular risk during prophylaxis of graft rejection in renal transplant recipientscardiovascular risk while preventing rejection of kidney transplant1003843010057166NL-OMON45007niversity Hospital Uppsala50
已完成
不适用
Risk factor profiling for future arterial cardiovascular events in patients wih unprovoked pulmonary embolismvenous embolism1001108210014523pulmonary embolismNL-OMON34542eids Universitair Medisch Centrum250